Font Size: a A A
Keyword [advanced hepatocellular carcinoma]
Result: 61 - 80 | Page: 4 of 7
61. Retrospective Clinical Study Of TACE Combined With Apatinib In The Treatment Of Advanced Hepatocellular Carcinoma
62. The Efficacy And Safety Of PD-1/PD-L1 Inhibitors Monotherapy In Advanced Hepatocellular Carcinoma:a Meta Analysis
63. Clinical Study On Treatment Methods And Efficacy Of Advanced Hepatocellular Carcinoma
64. Relationship Between Gut Microbiome And Exosomal PD-L1 Expression And The Efficacy Of PD-1 Blockade Therapy In Advanced Hepatocellular Carcinoma
65. Clinical Efficacy Of Sorafenib Combined With TACE In The Treatment Of Middle And Advanced Hepatocellular Carcinoma
66. Relationship Between18f-fluorodeoxyglucose Uptake And Response To PD-1 Inhibitor Nivalumab In Advanced Hepatocellular Carcinoma
67. Comparison Of Different Liver Function Evaluation Methods In Predicting Liver Injury After Tace For Advanced Hepatocellular Carcinoma
68. Effect Of Fatigue On Prognosis Of Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
69. Analysis Of Efficacy And Safety Of Different TACE Combined Sorafenib Treatment Models In The Treatment Of Advanced Hepatocellular Carcinoma
70. The Clinical Efficacy Of Transarterial Chemoembolization Combined With Anlotinib In The Treatment Of Advanced Hepatocellular Carcinoma
71. Clinical Study Of Apatinib Combined With Transcatheter Arterial Chemoembolization In Patients With Advanced Hepatocellular Carcinoma
72. The Clinical Study Of Prescription Of Yugansanjie Combined With Cinobufacini Injection In The Treatment Of Advanced Hepatocellular Carcinoma
73. Clinical Analysis Of Lenvatinib Monotherapy And Combination Therapy For Advanced Hepatocellular Carcinoma
74. Comparative Study Of TACE Combined With Camrelizumab And TACE Alone In The Treatment Of Advanced Hepatocellular Carcinoma
75. Cost-effectiveness Analysis Of Hepatic Arterial Infusion Of Chemotherapy Combined Sorafenib For Advanced Hepatocellular Carcinoma
76. Safety And Clinical Efficacy Of TACE Combined With Camrelizumab And Apatinib On Advanced Hepatocellar Carcinoma
77. The Comparison Of Efficacy And Safety Between Apatinib And Sorafenib In The Treatment Of Advanced Hepatocellular Carcinoma Of Real World
78. Association Between HJURP Gene Polymorphism And Clinical Outcomes Of Advanced Hepatocellular Carcinoma Treated With Oxaliplatin-based Chemotherapy
79. Clinical Observation Of Apatinib Combined With Carrelizumab In The Treatment Of Advanced Hepatocellular Carcinoma
80. Early Alpha-fetoprotein Response Associated With The Efficacy And Prognosis In Advanced Hepatocellular Carcinoma Treated With Lenvatinib
  <<First  <Prev  Next>  Last>>  Jump to